July 28, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on July 27 supported approval for Pfizer’s breast cancer drug palbociclib, known as Ibrance overseas, paving the way for its official green light in September. Palbociclib was...read more